Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-01-27 4:30 pm Unchanged | 13D | ARTARA THERAPEUTICS INC TARA | Opaleye Management Inc. | 5,036,010 37.79% | 0 (Unchanged) | View |
2020-01-21 5:15 pm Purchase | 13D | ARTARA THERAPEUTICS INC TARA | Opaleye Management Inc. | 5,036,010 37.79% | 5,036,010 (New Position) | View |
2020-01-21 5:15 pm Purchase | 13G | SANUWAVE HEALTH INC SNWV | Opaleye Management Inc. | 14,717,714 5.08% | 14,717,714 (New Position) | View |
2020-01-10 4:30 pm Purchase | 13G | OCULAR THERAPEUTIX INC OCUL | Opaleye Management Inc. | 5,126,000 10.66% | 2,926,000 (+133.00%) | View |
2019-12-27 4:30 pm Purchase | 13G | APTOSE BIOSCIENCES INC NO APTO | Opaleye Management Inc. | 4,085,000 5.52% | 4,085,000 (New Position) | View |
2019-11-22 4:30 pm Purchase | 13G | FORTRESS BIOTECH INC FBIO | Opaleye Management Inc. | 3,817,300 5.39% | 3,817,300 (New Position) | View |
2019-11-07 4:30 pm Purchase | 13G | EDAP TMS S.A. SPONS ADR EDAP | Opaleye Management Inc. | 1,520,500 5.24% | 1,520,500 (New Position) | View |
2019-08-16 4:30 pm Purchase | 13G | STEREOTAXIS INC STXS | Opaleye Management Inc. | 4,065,100 6.16% | 4,065,100 (New Position) | View |
2019-05-24 5:20 pm Sale | 13G | ETON PHARMACEUTICALS INC ETON | Opaleye Management Inc. | 881,678 5% | -840,322 (-48.80%) | View |
2019-05-03 5:15 pm Purchase | 13G | OCULAR THERAPEUTIX INC OCUL | Opaleye Management Inc. | 2,200,000 5.14% | 2,200,000 (New Position) | View |